Viewing Study NCT00376818



Ignite Creation Date: 2024-05-05 @ 5:03 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00376818
Status: COMPLETED
Last Update Posted: 2012-06-04
First Post: 2006-09-13

Brief Title: Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers
Sponsor: Case Comprehensive Cancer Center
Organization: Case Comprehensive Cancer Center

Study Overview

Official Title: Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers
Status: COMPLETED
Status Verified Date: 2012-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE Yoga meditation and breathing exercises may help lower stress and improve quality of life in patients with malignant brain tumors and their family caregivers

PURPOSE This clinical trial is studying how well a stress reduction program works to improve the quality of life of patients with malignant brain tumors and their family caregivers
Detailed Description: OBJECTIVES

Primary

Determine whether regular practice of a stress reduction program for 8 weeks improves the quality of life of patients with malignant brain tumors

Secondary

Determine whether regular practice of a stress reduction routine decreases perception of stress and anxiety and stress- and inflammation-related hormones in both patients with malignant brain tumors and their primary family caregivers

OUTLINE This is a pilot study

Patients and caregivers receive a 90-minute stress-reduction session once a week for 8 weeks Each session comprises an educational session on stress reduction and yoga therapy comprising specific yoga postures breathing exercises and relaxation and meditation

Quality of life stress anxiety and levels of stress-related hormones cortisol dehydroepiandrosterone sulfate DHEAS and melatonin are assessed at baseline and at week 8

After completion of study treatment patients and caregivers are followed at 6 and 12 months

PROJECTED ACCRUAL A total of 14 caregiverpatient pairs will be accrued for this study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
P30CA043703 NIH None httpsreporternihgovquickSearchP30CA043703